Mashup Score:16
Medical XpressClinical trial leads to atezolizumab approval for advanced alveolar soft part sarcoma - 1 month
Mashup Score:16
# atezolizumab
Mashup Score:4
OncLiveFDA Approves Atezolizumab for Alveolar Soft Part Sarcoma - 1 month
Mashup Score:4
The FDA has approved atezolizumab (Tecentriq) for adult and pediatric patients aged 2 years and older with unresectable or metastatic alveolar soft part...
-
ICYMI: The @US_FDA has approved #atezolizumab (#Tecentriq) for adult and pediatric patients aged 2 years and older with unresectable or metastatic alveolar soft part sarcoma. #scmsm https://t.co/zDwXfPZrog - view on twitter
Mashup Score:1
OncLiveFDA Approves Atezolizumab for Alveolar Soft Part Sarcoma - 1 month
Mashup Score:1
The FDA has approved atezolizumab (Tecentriq) for adult and pediatric patients aged 2 years and older with unresectable or metastatic alveolar soft part...
-
ICYMI: The @US_FDA has approved #atezolizumab (#Tecentriq) for adult and pediatric patients aged 2 years and older with unresectable or metastatic alveolar soft part sarcoma. #scmsm https://t.co/QX2hVgq21O https://t.co/QX2hVgq21O - view on twitter
Dr Millie Das, MD opens a discussion surrounding updates regarding non-small cell lung cancer (NSCLC) as presented at the 2022 World Conference on Lung...
-
In our Post Conference Perspectives series for #WCLC22, Dr Millie Das (@DasMillie11) opens a discussion surrounding updates regarding #NSCLC, including results of the #IMpower010 trial evaluating #atezolizumab vs best supportive care. https://t.co/PvxrhFWNO7 @IASLC https://t.co/PvxrhFWNO7 - view on twitter
Atezolizumab has been granted FDA approval for patients aged 2 years and older with unresectable or metastatic alveolar soft part...
-
Atezolizumab Gets Green Light in Alveolar Soft Part Sarcoma #Atezolizumab #oncology #nursing #FDA #approval https://t.co/xNCadTpHbr - view on twitter
Stephen V. Liu, MD, discusses the effect of the FDA approval of atezolizumab on the development of other chemoimmunotherapy regimens and ongoing efforts to...
-
.@StephenVLiu, of @LombardiCancer, discusses the effect of the FDA approval of #atezolizumab on the development of other chemoimmunotherapy regimens and ongoing efforts to expand and individualize treatment options in SCLC. #lcsm https://t.co/riHZ1PRDzq https://t.co/riHZ1PRDzq - view on twitter
Atezolizumab administered before and during chemoradiation appeared safe and demonstrated immune-modulating activity among women with node-positive locally advanced cervical cancer, according to study results....
-
#CervicalCancerAwarenessMonth Atezolizumab administered before and during chemoradiation appeared safe and demonstrated immune-modulating activity. https://t.co/nPu4LdfILk #Tecentriq @genentech #womenshealth #Atezolizumab #CervicalCancer #Cancer #HemOnc #OncAlert #MedEd - view on twitter
More coverage:
#atezolizumab
#cancer
#cervicalcancer
#cervicalcancerawarenessmonth
#hemonc
#meded
#oncalert
#tecentriq
#womenshealth
A clinical trial led by the National Cancer Institute (NCI), part of the National Institutes of Health, has resulted in the first approval of...
Clinical trial leads to #atezolizumab approval for advanced alveolar soft part sarcoma @theNCI https://t.co/nAcbWnYHEc - view on twitter